Proper Joint Care Cardiovascular health Immunity Allergy

HOME > Research

Visitor:759


Proper Joint Care
  1. 1. Elders, MJ. (2000). The increasing impact of arthritis on public health, J. Rheumatol Suppl; 60:6-8.
  2. 2. Yi-Xuan Cai, Chen-Liang Chou (2006). Common Osteoarthritis of Knee and Hand. Clinical Medicine, 58 (6), 423-427.
  3. 3. Brooks, P. (1998). Use and benefits of nonsteroidal anti-inflammatory drugs, Am J Med; 104:9S-13S; 30 Mar discussion 21S-22S.
  4. 4. Scheiman, J.M. (1996). NSAIDs, gastrointestinal injury, and cytoprotection, Gastroenterology Clin North Am. 25:279-298.
  5. 5. Bolten, W.W. (1998). Scientific rationale for specific inhibition of COX-2, J Rheumatol Suppl 51:2-7.
  6. 6. Peura, D.A. (2002). Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors. Cleve Clin J Med 69: Suppl:SI 31-9.
  7. 7. Gabriel, S.E., Jaakimainen, L., Bombardier, C. (1991). Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787-796.
  8. 8. Philippi, A.F., Christopher, L.T., Leffler, M.C., Mosure, J.C. & Kim, P.D. (1999). Glucosamine, Chondroitin and Manganese Ascorbate for Degenerative Joint Disease of theKnee or Low Back: A Randomized, Double Blind, Placebo Controlled Pilot Study. Military Medicine. 164:85-919.
  9. 9. da Camara, C.C. & Dowless, G.V. (1998). Glucosamine sulfate for osteoarthritis. Ann Pharmacother, 32(5):580-7 Decision Research.
  10. 10. Miles, P.D., Higo, K., Olefsky, J.M. (2001). Exercise-stimulated glucose turnover in the rat is impaired by glucosamine infusion. Diabetes 50(1): 139-142.
  11. 11. Heart, E., Choi, W.S. & Sung, C.K. (2000). Glucosamine-induced insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 278: E103-E112.
  12. 12. Ormrod, D.J., Miller, T.E. (1992). A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil emigration. Agents and Actions 37: 70-79.
  13. 13. Stelwagen, K. & Ormrod, D.J. (1998). An anti-inflammatory component derived from milk of hyperimmunised cows reduces tight junction permeability in vitro. Inflamm res, 47:384-388.
  14. 14. Owens, W.E., Nickerson, S.C. & Washburn, P.J. (1992). Effect of a milk-derived factor on the inflammatory response to Staphylococcus aureus intramammary infection. Veterinary Immunology and Immunopathology 30: 233-246.
  15. 15. Ormrod, D.J. & Miller, T.E. (1991). The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperimmunized cows. Agents and Actions 32:160-166.
  16. 16. Ormrod, D.J. & Miller, T.E. (1993). Milk from hyperimmunized dairy cows as a source of a novel biological response modifier. Agents and Actions 38:146-149; 1993.
  17. 17. Zenk, J.L., Heimer, T.R., Kuskowski, M.A. (2002). The Effects of Milk Protein Concentrate on the Symptoms of Osteoarthritis in Adults: An Exploratory, Randomized, Double-Blind, Placebo-Controlled Trial. Current Therapeutic Research 63:430-442.
  18. 18. Colker, C.M., Swain, M., Lynch, L. & Gingerich, D.A. (2002). Effects of a Milk-Based Bioactive Micronutrient Beverage on Pain Symoptoms and Activity of Adults with Osteoarthritis: A Double-blind, Placebo-Controlled, Clinical Evaluation Nutrition 18:388-392.
  19. 19. Beck, L.R. (1988). Milk AIF suppression of TPA induced inflammation of the mouse ear (SMBI Internal Source).
  20. 20. Young, J.M., Wagner, B.M., Spires, D.A. (1983). Tachyphylaxis in 12-0-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema. J Invest Dermatol. 80:48.-52.
  21. 21. Bellamy, N., Buchanan, W.W., Goldsmith, C.H., Campbell, J. & Stitt, L.W. (1998). Validation Study of WOMAC: A Health Status Instrument for Measuring Clinically Important Patient Relevant Outcomes to Antirheumatic Drug Therapy in Patients with Osteoarthritis of the Hip or Knee. J Rheumatol. 15:1833-1840.
  22. 22. Hedges, L.V. (1981). Distribution Theory for Glass's Estimator of Effect Size and Related Estimators; J Educ Stat. 6:107-28.
  23. 23. Roos. E.M., Roos, H.P., Lohmander, L.S., Ekdahl, C. & Beynnon, B.D. (1988). Knee Injury and Osteoarthritis Outcome Score (KOOS) – Development of a Self-Administered Outcome Measure. J Orthop Sports Phys Ther. 78:88-96.
  24. 24. Schimmer BP, Parker KL. (1996). Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; Inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Phannacotogicat Basis of Therapeutics. 9th ed. New York: McGraw-Hill;1470-1471.
  25. 25. Stolle, R.J. & Beck, L.R. (1988). Prevention and Treatment of Rheumatoid Arthritis. US Patent #4,732,757.
  26. 26. Beck, L.R. & Fuhrer, J.P. (1999). Anti-inflammatory factor, method of isolation, and use. US Patent #5,980,953.
  27. 27. The Ohio Survey Results and Methods, 1961-1989, Archives. In: Beck LR. SMBI; Cincinnati, Ohio, 1989:32-55.
Immune today, healthy everyday.
回上一頁置上

These statements have not been evaluated by the Food and Drug Administration.

The products mentioned here are not intended to diagnose, treat, cure or prevent any disease.